Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
GlaxoSmithKline’s Sligo plant will close the plant and lay off its 165 workers over the next three years.
read more
Delpharm, will acquire GlaxoSmithKline’s Poznan manufacturing facility in Poland.
read more
Thursday, August 31, 2017
GlaxoSmithKline has selected SciBite's Semantic Platform to enhance pharmacovigilance capabilities and deliver on its commitment to improve the quality of human life.
read more
Wednesday, August 12, 2015
GlaxoSmithKline shut down a plant Tuesday that produces inhaled medications after discovering the bacteria that causes Legionnaire's disease, a potentially fatal form of pneumonia.
read more
Wednesday, December 13, 2023
Ginkgo Bioworks has been awarded a grant by the Bill & Melinda Gates Foundation to advance a groundbreaking cell-based technology, aiming to enhance the delivery of protein therapeutics to patients in low- and middle-income countries (LMICs).
read more
Ginkgo Bioworks announced the opening of Bioworks7, the latest expansion of its biological engineering foundry. With this new space, Ginkgo increases its capacity and capabilities to serve its partners in the spaces of cell and gene therapy, ...
read more
Monday, November 03, 2025
Ginkgo Bioworks has been awarded a contract through the Biomedical Advanced Research and Development Authority's (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) to develop innovations that strengthen and reduce the...
read more
The Defense Advanced Research Projects Agency (DARPA) announced that Ginkgo Bioworks has been awarded a 4-year contract worth up to $18 million to reimagine how to manufacture complex therapeutic proteins.
read more
Thursday, September 01, 2022
Ginkgo Bioworks announced that Behzad Mahdavi, Ph.D., MBA, joined as senior vice president of biopharma manufacturing and life sciences tools.
read more
Wednesday, August 09, 2023
Ginkgo Bioworks announced a new collaboration with Merck focused on improving biologic manufacturing.
read more
Tuesday, October 11, 2022
Ginkgo Bioworks is collaborating with Merck to engineer up to four enzymes for use as biocatalysts in Merck's active pharmaceutical ingredient (API) manufacturing efforts.
read more
Wednesday, October 05, 2022
Ginkgo Bioworks made a tuck-in acquisition of Circularis, a biotechnology company with a proprietary circular RNA and promoter screening platform.
read more
Tuesday, November 12, 2024
Gilero, a Sanner Group Company, is expanding its manufacturing capabilities with a new 60,500 square foot (5,620 square meter) facility in Greensboro, North Carolina.
read more
Gilead Sciences and Nurix Therapeutics announced a collaboration to discover, develop and commercialize a pipeline of targeted protein degradation drugs for patients with cancer.
read more
Monday, December 30, 2019
Gilead Sciences and Eisai announced the two companies have entered into an agreement for the distribution and co-promotion of filgotinib, pending regulatory approval for rheumatoid arthritis.
read more